Comparative Proteomics for the Evaluation of Protein Expression and Modifications in Neurodegenerative Diseases

Antonio Conti, Massimo Alessio

Research output: Chapter in Book/Report/Conference proceedingConference contribution


Together with hypothesis-driven approaches, high-throughput differential proteomic analysis performed primarily not only in human cerebrospinal fluid and serum but also on protein content of other tissues (blood cells, muscles, peripheral nerves, etc.) has been used in the last years to investigate neurodegenerative diseases. Even if the goal for these analyses was mainly the discovery of neurodegenerative disorders biomarkers, the characterization of specific posttranslational modifications (PTMs) and the differential protein expression resulted in being very informative to better define the pathological mechanisms. In this chapter are presented and discussed the positive aspects and challenges of the outcomes of some of our investigations on neurological and neurodegenerative disease, in order to highlight the important role of protein PTMs studies in proteomics-based approaches.

Original languageEnglish
Title of host publicationInternational Review of Neurobiology
PublisherAcademic Press Inc.
Number of pages36
ISBN (Print)9780128014806
Publication statusPublished - 2015

Publication series

NameInternational Review of Neurobiology
ISSN (Print)00747742


  • Amyotrophic lateral sclerosis
  • Biomarker
  • Cerebrospinal fluid
  • Mass spectrometry
  • Parkinson's disease
  • Posttranslational modifications
  • Two-dimensional electrophoresis

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Medicine(all)


Dive into the research topics of 'Comparative Proteomics for the Evaluation of Protein Expression and Modifications in Neurodegenerative Diseases'. Together they form a unique fingerprint.

Cite this